Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 5ZCQ | P00430 | Azide-bound cytochrome c oxidase structure determined using the crystals exposed to 10 mM azide solution for 2 days | |
| 5ZCQ | P10175 | Azide-bound cytochrome c oxidase structure determined using the crystals exposed to 10 mM azide solution for 2 days | |
| 2PYH | Q44493 | Azotobacter vinelandii Mannuronan C-5 epimerase AlgE4 A-module complexed with mannuronan trisaccharide | |
| 7QE4 | F2UID9 | B-trefoil lectin from Salpingoeca rosetta in complex with GalNAc | |
| 7R55 | F2UID9 | B-trefoil lectin from Salpingoeca rosetta in complex with Gb3 | |
| 3CK7 | Q8A1G2 | B. thetaiotaomicron SusD with alpha-cyclodextrin | |
| 3CK8 | Q8A1G2 | B. thetaiotaomicron SusD with beta-cyclodextrin | |
| 3CK9 | Q8A1G2 | B. thetaiotaomicron SusD with maltoheptaose | |
| 3CKB | Q8A1G2 | B. thetaiotaomicron SusD with maltotriose | |
| 6EDU | B3UEZ6 | B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 | Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain |
| 6EDU | B3UES2 | B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 | Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain |
| 6EDU | P01730 | B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 | Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain |
| 6EDU | 6EDU | B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 | Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain |
| 6OKP | B3UEZ6 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | |
| 6OKP | B3UES2 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | |
| 6OKP | S6B291 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | |
| 6OKP | 6OKP | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | |
| 6OKP | S6B291 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | |
| 6OKP | 6OKP | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | |
| 6OKP | Q8N5F4 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | |
| 6OKP | Q8N5F4 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | |
| 6OKP | P01834 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | |
| 6OKP | P01834 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | |
| 8OWW | P0DTC2 | B5-5 nanobody bound to SARS-CoV-2 spike RBD (Wuhan) | |
| 8OWW | 8OWW | B5-5 nanobody bound to SARS-CoV-2 spike RBD (Wuhan) | |
| 8AQU | P01865 | BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQU | Q8R0I0 | BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQU | P10104 | BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQU | P0DTC2 | BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8WGV | P0DTC2 | BA.2(S375) Spike (S6P)/hACE2 complex | |
| 8WGV | Q9BYF1 | BA.2(S375) Spike (S6P)/hACE2 complex | |
| 8CIM | P10104 | BA.2-07 FAB IN COMPLEX WITH SARS-COV-2 BA.2.12.1 SPIKE GLYCOPROTEIN | |
| 8CIM | P0DTC2 | BA.2-07 FAB IN COMPLEX WITH SARS-COV-2 BA.2.12.1 SPIKE GLYCOPROTEIN | |
| 8CIM | 8CIM | BA.2-07 FAB IN COMPLEX WITH SARS-COV-2 BA.2.12.1 SPIKE GLYCOPROTEIN | |
| 8AQV | P01865 | BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQV | Q8R0I0 | BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQV | P10104 | BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQV | P0DTC2 | BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8WHZ | Q9BYF1 | BA.2.86 RBD in complex with hACE2 (local refinement) | |
| 8WHZ | P0DTC2 | BA.2.86 RBD in complex with hACE2 (local refinement) | |
| 8Y4A | P0DTC2 | BA.2.86 S-trimer in complex with Nab XG2v046 | |
| 8Y4A | 8Y4A | BA.2.86 S-trimer in complex with Nab XG2v046 | |
| 8Y4C | P0DTC2 | BA.2.86 S-trimer in complex with Nab XGv280 | |
| 8Y4C | 8Y4C | BA.2.86 S-trimer in complex with Nab XGv280 | |
| 8XUR | P0DTC2 | BA.2.86 Spike Trimer in complex with heparan sulfate | |
| 8X56 | P0DTC2 | BA.2.86 Spike Trimer with T356K mutation (1 RBD up) | |
| 8X55 | P0DTC2 | BA.2.86 Spike Trimer with T356K mutation (3 RBD down) | |
| 8X50 | P0DTC2 | BA.2.86 Spike Trimer with ins483V mutation (1 RBD up) | |
| 8X4Z | P0DTC2 | BA.2.86 Spike Trimer with ins483V mutation (3 RBD down) | |
| 8XZA | Q2HJI5 | BA.2.86 Spike in complex with bovine ACE2 (Local refinement) |
